Safety and Tolerability of Liraglutide in Healthy Japanese Volunteers

Inclusion Criteria: * Healthy * Japanese * Body mass index (BMI) between 18 and 27 kg/m\^2 inclusive Exclusion Criteria: * Any clinical laboratory values deviated from the reference range at the laboratory * Presence of diabetes, cancer or any clinically significant cardiac, respiratory, metabolic, renal, hepatic, gastrointestinal, endocrinological, dermatological, venereal, haematological, neurological, or psychiatric diseases or disorders * Hepatitis B surface antigen, Hepatitis C antibodies or HIV (human immunodeficiency virus) antibodies positive * History of diabetes, cancer or any clinically significant cardiac, respiratory, metabolic, renal, hepatic, gastrointestinal, endocrinological, dermatological, venereal, haematological, neurological, or psychiatric diseases or disorders. * History of significant allergy or hypersensitivity * Known or suspected allergy to trial product or related products. * History of drug or alcohol abuse * Smokes more than 15 cigarettes, or the equivalent, per day andis unwilling to refrain from smoking whenever required for the trial procedure